Research Interest:  pharmacological approaches in human ex vivo / in vitro models targeted against inflammation&proliferation&migration in atherosclerosis and restenosis following angioplasty.

Research Interest:  Designing and preparing new nanobiomaterials,  Characterizing physical and chemical properties, biocompatibility and bioactivity of the nanobiomaterials

Prof Ahmed Idris Hassen is an Applied Microbiologist (PhD) currently based in South Africa.  He received his BSc degree in Biology and MSc degree in Food Microbiology in Ethiopia, and his PhD degree in Applied Microbiology from the University of Pretoria, South Africa. He has several years of teaching and lecturing experience in the fields of Biology and General Microbiology in Ethiopia. Currently he works as a research scientist and conducts research at the Agricultural Research Council, Plant Health and Protection in South Africa with a major research focus on Applied Microbiology for use in sustainable and climate smart agriculture. Priority research areas include plant-microbe interactions of the legume-rhizobium symbiosis, plant growth promoting rhizobacterial interactions in the rhizosphere of economically important crops, as well as biological control of soilborne diseases and development of insecticidal Bacillus thuringiensis (Bt) against common insect pests of crops. In addition, he conducts guest lecturing and supervision/co-supervision of postgraduate students in collaboration with higher education institutions as well as research and development collaboration with overseas scientists.

Research Interest(s): Plant Microbiology, Rhizobium-legume symbiotic interaction, molecular microbiology, microbial ecology, biocontrol of pests/pathogens using beneficial microbes, genomics 

URL of your official website:  https://www.arc.agric.za 

Research Interest: Aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr. Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001) in mammalian cells. Dr. Yamaguchi generated regucalcin transgenic rats, which were registered as international patents (USA, EU, Japan, and Korea), and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis.  Currently, the research of regucalcin is focused as a scientific topic 

Research Interest: Pharmacology/Toxicology Isolation and Identification of Natural products, Drug Discovery and Development, Cellular and Molecular Biology of Diseases 

Research Interest: Biological activity of blood platelets; inflammatory properties of platelets; interaction of blood platelets with the cells of the immune system; autoimmune diseases; activation and platelet reactivity in neurodegenerative diseases (multiple sclerosis); proteome, transcriptome and metabolome of platelets; molecular markers of platelets in the diagnosis of acute coronary syndromes

Research Interest: Gentics; Tree Genetic Improvement; Plant Biotechlology

Research Interest: Methodology of solid phase peptide synthesis and synthetic peptides with bioactivity

Research Interest:  A versatile biotechnologist with research experience ranging from searching for novel microbial enzymes using classical and metagenomic approaches, genetic engineering to tailor them for specific applications, fermentation, downstream processing and their biotechnological application. Biotechnological applications range from developing “Green Chemistry technologies”/processes, developing antimicrobial systems, and systems/and or products for preventing, monitoring and therapy of oxidative stress related human diseases (cancer, cardiovascular, respiratory, atherosclerosis, diabetes, neurodegenerative diseases).

Research Interest:  Neurogenesis. Screening the leading chemical to stimulate the neurogenesis after CNS, diseases, including: Stroke, Multiple sclerosis, Alzheimers disease et al.  Brain tumor. To study the oncogenesis mechanisms of mellablastoma and glioblastoma.At the same time, to screen the inhibitor of Sonic hedgehog pathway to treat the brain tumor.

Research Interest: Molecular biology as well as signaling pathways involved in apoptosis.

Research Interest: Biomedical applications of Nanotechnology, Nano Particulate Drug Delivery systems, Antibody mediated drug delivery systems, Nano-Nutraceuticals and Nano dispersed Systems, and educational research

Research Interest: Polymer-based inorganic nanocomposite, biomass composite materials

Research Interest: Regulation of extracellular matrix genes and growth factors by potential anti-skin aging, anti-carcinogenic or wound repair agents in normal or cancer cells:Area of Expertise: Biochemistry and Cell/Molecular Biology; Biotechnology: Cell culture, Gene Regulation (protein, mRNA, promoter levels), Extracellular matrix (collagen, matrixmetalloproteinases, elastin, fibrillin), Growth factors/cytokines (tranaforming growth factor-b, interleukins), Oxidative Stress/Reactive Oxygen species, Antioxidants, Apoptosis, Toxicity, Angiogenesis/Metastasis.

Research Interest:  Green materials processing, surface coating, nanomaterials, energy materials and biomaterials